Received May 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
3 or 4 inch red blotch that lasted about 2 weeks, 2 or 3 weeks; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (3 or 4 inch red blotch that lasted about 2 weeks, 2 or 3 weeks) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) (batch nos. 3030433 and 80304333) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form and dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (3 or 4 inch red blotch that lasted about 2 weeks, 2 or 3 weeks). At the time of the report, RASH MACULAR (3 or 4 inch red blotch that lasted about 2 weeks, 2 or 3 weeks) had resolved. No concomitant medications provided by the reporter. Patient had been receiving Moderna consistently and always had a 3 or 4 inch red blotch which lasted about 2 or 3 weeks. Patient also experienced the "red blotch" on arm from the vaccine with a lot number of 3030433 or 80304333. Patient that had a hard time reading the information from her vaccination document/card. Patient don't have time to read all the lot numbers. It was unknown if the patient experienced any additional symptoms/events. No treatment medications provided by the reporter. This case was linked to MOD-2026-795389 (Patient Link).